Keyphrases
Adjuvant Therapy
100%
Sentinel Lymph Node Biopsy
100%
Melanoma Patients
100%
Completion Lymphadenectomy
100%
Positive Sentinel Lymph Node
100%
Completion Lymph Node Dissection
66%
Active Surveillance
33%
Recurrence-free Survival
22%
Tumor
11%
T-test
11%
Surgical Resection
11%
Patient Tumor
11%
Disease Pattern
11%
Demographic Information
11%
Inclusion Criteria
11%
High-risk Disease
11%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
11%
Melanoma
11%
Randomized Trial
11%
Fisher's Exact Test
11%
1-year Recurrence
11%
Treatment Characteristics
11%
Patient Treatment
11%
Ipilimumab
11%
Anti-programmed Death 1
11%
Programmed death-1 Inhibitor
11%
Lymph Node Disease
11%
BRAF Inhibitor (BRAFi)
11%
SLN Biopsy
11%
Nivolumab
11%
Acral Lentiginous
11%
Recurrence Treatment
11%
Information Characteristics
11%
Medicine and Dentistry
Adjuvant Therapy
100%
Sentinel Lymph Node Biopsy
100%
Retroperitoneal Lymph Node Dissection
100%
Melanoma
100%
Sentinel Lymph Node
66%
Recurrent Disease
55%
Neoplasm
22%
Disease
22%
Recurrence Free Survival
22%
Cytotoxic T-Cell
11%
Surgery
11%
Biopsy Technique
11%
Fisher Exact Test
11%
Student T Test
11%
Venous Ulcer
11%
Lymphadenopathy
11%
MEK Inhibitor
11%
Ipilimumab
11%
Nivolumab
11%